Exploring 4 years of HIV pre-exposure prophylaxis as a statutory health insurance benefit in Germany-a longitudinal claims data analysis.

ABSTRACT:

Background

Introduction of HIV pre-exposure prophylaxis (PrEP) into German statutory health insurance in September 2019 reduced barriers to an effective tool for HIV prevention.

Objective

This study aims to provide a longitudinal analysis of HIV-PrEP care in a real-world setting in Germany between 09/2019-08/2023 using claims data from the insurance provider BARMER.

Methods

We assessed anonymized claims data to analyze PrEP care and user characteristics. PrEP courses were defined and analyzed based on initiations, discontinuations and reinitiations, as well as proportion of days covered (PDC) as metric of adherence, post-exposure prophylaxis (PEP) and incident HIV infections.

Results

A total of 5,208 PrEP users with a median and average observation time of 1.3

SUBMITTER: Schmischke S 

PROVIDER: S-EPMC12626964 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature